Additionally, xanthine oxidase inhibition has been closely related with diminution in uric acid levels and attenuation of fat accumulation in liver cells [35]; thus, xanthine oxidase inhibitors could be considered as putative therapies against MASLD development, especially when hyperuricemia appears [36]. Here, XDH is linked to hyperuricemia.